Sanofi (SNY) Change in Working Capital (2009 - 2026)

Sanofi has disclosed Change in Working Capital across 18 years of filings, most recently posting -$406.2 million for Q1 2026.

• Change in Working Capital for Q1 2026 came in at -$406.2 million, down 302.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 billion (up 127.74% YoY), and the FY2025 annual result was $317.8 million, up 337.33% from the prior year.
• Change in Working Capital came in at -$406.2 million for Q1 2026 at Sanofi, down from $2.4 billion in the prior quarter.
• In the past five years, Change in Working Capital ranged from a high of $2.4 billion in Q4 2025 to a low of -$1.9 billion in Q1 2024.
• The 5-year median for Change in Working Capital is -$49.0 million (2023), against an average of $82.6 million.
• Peak annual rise in Change in Working Capital reached 997.74% in 2022, while the deepest fall reached 21370.56% in 2022.
• Sanofi's Change in Working Capital stood at -$486.7 million in 2022, then surged by 145.77% to $222.7 million in 2023, then slumped by 343.26% to -$541.8 million in 2024, then jumped by 550.12% to $2.4 billion in 2025, then tumbled by 116.66% to -$406.2 million in 2026.
• The last three Change in Working Capital figures came in at -$406.2 million (Q1 2026), $2.4 billion (Q4 2025), and $35.1 million (Q3 2025), per Business Quant data.